AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Role of Multimodality Imaging in Left Atrial Appendage Closure

RecruitingNAAges 18 Years - anyAllHungarian Institute of Cardiology
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The aim of the present prospective, randomized single-centre study is to examine the success rate, safety, overall preoperative and operative burden and long-time outcome of percutaneous left atrial appendage closure procedures after unimodal and multimodal preprocedural imaging. According to the investigators' primary hypothesis, simple, unimodal preprocedural imaging does not increase procedural burden of LAAC (total radiation dose, procedure time, fluoroscopy time, contrast amount). The investigators assume, that the success rate and safety of LAAC procedures is not reduced using unimodal preoperative imaging. Regarding to postoperative imaging, the investigators aim to compare the sensitivity of different imaging techniques in detecting postoperative complications. We assume, that multimodal imaging technique increases the accuracy and sensitivity of the detection of postoperative

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients, who have clinical indication to LAAC and are undergoing percutaneous LAAC procedure in Gottsegen National Cardiovascular Center from 10.03.2021 to 31.12.2025 * Age above 18 years * Informed consent * Legal capacity Exclusion Criteria: * Age under 18 years * Pregnancy * Incapacitation * Absence of consent * Esophageal stenosis or diverticulum * Active esophageal bleeding * CT-contrast agent allergy * Severe chronic kidney disease (GFR\<15 ml/min/1,73 m2) * Appendage thrombus (mobile/with significant embolic risk) * Life expectancy shorter than 12 months * Active infection * Significant mitral valve stenosis * Mechanical heart valve * Open heart surgery is indicated
๐Ÿ’Š

What it tests

  • Multimodal imaging
  • Standard imaging
๐Ÿ“

Where

1 site
Hungarian Institute of Cardiology (Gottsegen National Cardiovascular Center)
Budapest, Hungary
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy